FDA Import Refusal 112-1309314-1/2/3 — Ranbaxy Pharmaceuticals, Inc.
The FDA refused shipment 112-1309314-1/2/3 from Ranbaxy Pharmaceuticals, Inc. (United States) on May 5, 2006. The refused product falls under Drugs and Biologics — LOVASTATIN (ANTI-CHOLESTEREMIC). Cited charges: 118,179
Refusal Details
- Date
- May 5, 2006
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61JDY12 LOVASTATIN (ANTI-CHOLESTEREMIC)
- Charges
- 118,179